1. Academic Validation
  2. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents

Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents

  • Eur J Med Chem. 2014 Oct 30:86:211-8. doi: 10.1016/j.ejmech.2014.08.050.
Gurleen Kaur 1 Mohinder P Mahajan 2 Manoj K Pandey 3 Parvesh Singh 4 Srinivasa R Ramisetti 3 Arun K Sharma 3
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Apeejay Stya University, Plot No. 23, Institutional Area, Sector-32, Gurgaon 122001, India.
  • 2 School of Pharmaceutical Sciences, Apeejay Stya University, Plot No. 23, Institutional Area, Sector-32, Gurgaon 122001, India; Apeejay Stya Research Foundation, Plot No. 23, Institutional Area, Sector-32, Gurgaon 122001, India. Electronic address: mpmahajan@apeejay.com.
  • 3 Department of Pharmacology, Penn State Hershey Cancer Institute, CH72 Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
  • 4 School of Chemistry and Physics, University of Kwa-Zulu Natal (UKZN), Westville Campus, Durban 4000, South Africa.
Abstract

The synthesis of some novel Ospemifene derived analogs and their evaluation as anti-breast Cancer agents against MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) human breast Cancer cell lines are described. Few of these analogs for instance, compounds 6, 7 and 8 are shown to be more effective than recent Selective Estrogen Receptor Modulators (SERMs) i.e. Ospemifene and Tamoxifen, against these cell lines. Compound 8 was relatively more cytotoxic to MCF-7 cells similar to Ospemifene and Tamoxifen, while most potent compounds 6 and 7 were equally effective in inhibiting growth of both ER-positive and ER-negative cell lines. The observed activity profiles were further supported by the docking studies performed against estrogen receptors (ERα and ERβ). Compounds 6, 7 and 8 exhibited stronger binding affinities with both ERα and ERβ compared to Ospemifene and Tamoxifen.

Keywords

Anti-breast cancer agents; Docking studies; Ospemifene; SERMs; Tamoxifen.

Figures
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》